WO1995026198A1 - Metal complexes of aloe extracts for skin and hair - Google Patents

Metal complexes of aloe extracts for skin and hair Download PDF

Info

Publication number
WO1995026198A1
WO1995026198A1 PCT/US1995/003777 US9503777W WO9526198A1 WO 1995026198 A1 WO1995026198 A1 WO 1995026198A1 US 9503777 W US9503777 W US 9503777W WO 9526198 A1 WO9526198 A1 WO 9526198A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
copper
gel
composition
ionic metal
Prior art date
Application number
PCT/US1995/003777
Other languages
French (fr)
Inventor
Loren R. Pickart
Original Assignee
Skin Biology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skin Biology, Inc. filed Critical Skin Biology, Inc.
Priority to AU21961/95A priority Critical patent/AU2196195A/en
Publication of WO1995026198A1 publication Critical patent/WO1995026198A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Definitions

  • aloe gel-metal complexes in the case of wound healing, and the extent of decreased follicle size in the case of impaired hair growth, and the general state of health of the patient being treated, but will generally range from about 1 mg to about 25 mg per day of aloe gel-metal complex per day per square centimeter of wound site, with dosages of from about 5 mg to about 10 mg per day per square centimeter of wound site being more commonly used. Maintenance dosages over a prolonged period of time may be adjusted as necessary. For veterinary uses higher levels may be administered as necessary. Determining actual amounts of the aloe gel-metal complexes necessary to treat a particular wound or condition as described above will be through standard empirical methods well known in the art.
  • This Example demonstrates the ability of aloe vera gel-copper complex to reduce inflammation associated with mild skin burns.

Abstract

Methods are provided for preparing compositions suitable for protecting irritated or damaged skin from further oxidative and biochemical damage and thus permitting natural healing processes to progress, for accelerating the rate of healing of burns and surgical wounds, and for increasing the size of hair follicles and the rate of hair growth. The compositions generally comprise complexes formed by the complexation of aloe vera with ionic metals such as copper(II) salts and tin(II) salts.

Description

METAL COMPLEXES OF ALOE EXTRACTS FOR SKIN AND HAIR
Background of the Invention
Extracts from the plant aloe have a traditional use for the treatment of skin and skin injuries. Liquid obtained from the epidermis of leaves of Aloe forms a gel that can be applied to skin injuries and wounds. For ease of use, the aloe extract may be processed to a dry powder which can be subsequently restored to a gel form by the addition of water.
Controlled laboratory studies of the healing actions of the preferred aloe extract, commonly named aloe vera, however, provide a confusing picture of its preferred ability to stimulate the skin healing process. In these studies aloe vera gel has variously been reported to stimulate the skin healing process, to have no effect, or even to delay wound healing. For example, Rodriguez-Bigas et al., Plast.
Reconstr. Surq. 81: 386-389 (1988) , found aloe vera gel to accelerate the healing of full-thickness burns in guinea pigs. Similarly, Davis and Maro, J. Am. Podiatr. Med. Assoc. 79: 24-26 (1989) , reported aloe vera to improve wound healing in diabetic mice. On the other hand, Schmidt and Greenspoon,
Obstet. Gvnecol. 78: 115-117 (1991) reported aloe vera gel to delay the healing of women after cesarean delivery or laparotomy for gynecologic surgery from an average of 53 days using standard wound management techniques to an average of 83 days in women treated with aloe vera gel. Watcher and
Wheeland, J. Dermatol. Surq. Oncol. 15: 188-1195 (1989) found no beneficial effect of aloe vera gel on the healing of surgical wounds in pigs. Kaufman et al. , J. Burn Care Rehabil. 9: 156-159 (1988) , concluded that aloe vera gel hindered the healing process of second degree burn wound in guinea pigs. Bracken et al., J. Occup. Med. 27: 733-739 (1985) , found that aloe vera gel did not improve the healing of hydrofluoric acid burns in rats. Currently, the general consensus seems to be that aloe vera extracts possess, at best, only a very mild healing action and are ineffective for the healing of more serious wound and injuries. The low efficacy and inconsistency of results with aloe vera gels has led to efforts to enhance a healing effect by various methods. Fulton, J. Dermatol. Surq. Oncol. 16: 460-467 (1990) , reported improved skin healing by using a stabilized aloe vera gel impregnated into a polyethylene oxide dressing. Davis et al., J. Am. Podiatr. Med. Assoc. 79:
559-562 (1989) , incorporated aloe vera gel into Eucerin cream and found improved healing of surgical wounds in rats.
Restoring the function of damaged and wounded skin continues to be a major health problem despite the development of various medications. Many approaches to skin-healing that are currently being developed, such as the production of growth factor proteins and pharmaceutical drugs with wound healing properties, and occlusive dressings for wounds, are beyond the economic reach of many patients. A major need exists for improved and low cost skin-care products and medicaments in less-developed countries, particularly in the tropics, where conditions such as inadequate health care, widespread skin fungal diseases, and the use of flammables such as kerosene for cooking and similar conditions give rise to high incidents of serious skin injury. For such countries, there is a critical need is to produce effective medicines that can be produced at very low cost using readily available materials. Even in more developed countries the increasing demands for cost-containment in medical services necessitate the development of low-cost products for skin care and pharmaceuticals for wound healing. Procedures such as hospitalization for the treatment of diabetic skin ulcers are increasingly being restricted. Thus, improved and cost- effective treatments for wound healing are required for the future.
Delayed healing or incomplete healing in humans and other animals causes additional pain and suffering for the patient and markedly increases wound complications and medical costs. Often the wound continues as a chronic sore that requires extensive attention and medical care to control infection and tissue necrosis. Even when such wounds finally heal, the wound area is frequently devoid of the ability to respond to tactile stimulation and is often filled with excessive deposits of immature collagen that produces permanent scarring. The urgent need for improved wound- healing compositions extends to wounds generated by surgical procedures. The success of surgical procedures, especially in very ill or elderly patients, is typically a function of the adequacy and speed of post-surgical healing.
Another aspect that can impair the normal healing response is excessive inflammation of injured or wounded skin. While the inflammatory process and its concomitant influx of white cells into the afflicted area are an integral part of the natural healing process, in some cases the inflammatory process becomes excessive and delays healing. The wounded tissue becomes locked in an early phase of the healing process and cannot proceed to completion. In such instances, compounds with anti-inflammatory activities are used to allow the process to proceed normally. One promising approach for the therapeutic treatment of conditions associated with inflammation and impaired wound healing has been the use of metal ions complexed to organic molecules or amino acids, amino acid derivatives and peptides. Some of these complexes possess anti-inflammatory activity, while others possess both anti-inflammatory activity and healing actions. Yet other complexes reportedly possess hair-growth stimulating actions in addition to anti-inflammatory and/or healing activities, as described in, for example, applicant's co-owned pending patent application serial no. 07/954,620, which is incorporated in its entirety by reference herein.
The use of copper salts or complexes as anti- inflammatory agents for the healing of stomach ulcers in the treatment of patients suffering from acute or chronic arthritis dates back to the 1940's and 1950's (see, e.g., reviews by Sorenson, Inflammation. 3:317-331 (1976) ; Agents and Actions 8:305-331 (1981), and Comprehensive Therapy 11:49-64 (1985)). The use of copper salts and complexes, such as copper-salicylate complex, seems to have been abandoned, apparently due to the early promise of the steroidal anti- inflammatories, such as hydrocortisone. Other complexes of copper with amino acids (tryptophan, lysine) , with non- steroidal anti-inflammatory drugs (indomethacin, ketoprofen, acetylsalicylic acid) or with fatty acids (oleic, lauric and caprylic acids) have been studied but, despite their promise, were rarely developed beyond the preclinical phases, apparently due to problems of irritation, toxicity, and inadequate efficacy.
While many copper-complexes have been reported to possess anti-inflammatory properties, a more limited group have been reported to also possess healing actions. Heintze (U.S. Pat. No. 4,123,511) reported that a copper oleate complex had anti-inflammatory and skin healing activity. Sorenson (U.S. Pat. No. 4,440,754) describes the use of complexes of copper(II) salts and amino acids, such as tryptophan or lysine, or with organic molecules such as 3,5- diisopropylsalicylic acid, acetylsalicylic acid or salicylic acid, to prevent and heal gastrointestinal ulcers. Using a wound-healing model, Townsend and Sorenson (Sorenson et al., Agents and Actions 8:305-325 (1981)) found salicylate-copper to accelerate the rate of healing and to improve the quality of healing of surgically-induced ulcers in rats. Also,
Sorenson wrote (ibid, and Inflammation 3: 317-331 (1976)) that Townsend demonstrated that coppe (II)-(tryptophan)2 increased the rate of ulcer healing in a surgically-induced ulcer model. The increased healing was purportedly due to a more rapid re- epithelialization of the wound and an increase in the quantity and quality of the collagen. Fine collagen fibers in a normal orientation developed in treated animals, in contrast to non- treated animals in which the new collagen was very dense and composed of thick, wavy disoriented bundles, resembling scar tissue.
Federici and Bertolotto (EP 450,398 and IT 9,019,948) reports that chondroitin sulfate-copper(II) complexes possessed anti-inflammatory activity. European Patent No. EP 66,283 discloses "eustatic" compositions which contain a non-toxic metal ion (including copper) and a glycosamino-glycan of hyaluronic acid or chondroitin sulfate useful as a cicatrizant (wound healing by closure) . UK Patent Application GB 2 044 265 describes metal complexes (including copper) of adenosine triphosphate as aiding the recovery of bone tissue in cases of fractures as well as in osteoporosis and bone cysts.
Konishi (US Pat. No. 4,461,724) reports that the tetrapeptide Gly-Ser-His-Lys and peptides of related structures possess anti-inflammatory and healing actions when complexed with metals such as ionic copper and zinc.
Yu (U.S. Patent 4,053,630) discloses the use of cysteic acid and its derivatives cysteine sulfinic acid or homocysteic acid, chelated to metal ions such as ferric, cupric, zinc or aluminum, to form compositions that alleviate symptoms of diseases characterized by defects of keratinization and achieved a remission of ichthyosis, dandruff and acne. Bertelli (U.S. Patent 4,156,737) suggests that copper complexes of p-aminomethyl-benzene-sulfonamide possess healing and protective effects on skin burns. Van Scott (U.S. Patent 4,283,386) reports that metallic (copper, zinc, or aluminum) salt forms of cysteic acid, cysteine sulfinic acid and homocysteic acid have therapeutic actions that produce remissions of dry and broken skin, keratoses, warts and palmar and plantar hyperkeratosis.
Niwa .Dermatoloqica 179 SI: 101-106 (1989)) and Bergren et al. (Am. Surq.. 54: 333-336 (1988)) found that the anti-inflammatory protein Cu, Zn-superoxide dismutase also acts to enhance healing processes.
Pickart (see, e.g., PCT Publications WO 91/14437, WO 91/12267, WO 91/05797, WO 91/03488, WO 89/12441, WO 88/26448, WO 88/08851, EP Patents EP 190,736, EP 189,182; and U.S. Pat. No. 4,767,753) describes the synthesis and use of metal complexes of Gly-L-His-L-Lys as anti-inflammatory and healing agents.
A number of metal complexes have been used to promote hair growth. Yamashiki (Japan Pat. 70018997) used a complex of copper-pantothenate to purportedly promote growth of hair roots and promote skin functions. Morelle (U.K. Pat. GB 2097256, DE Pat. 32212448) used amino acid derivatives (N- butyryl amino acids) complexed with copper and other metals for cosmetic and therapeutic purposes, including use as hair and skin stimulants. Banfi et al. (U.S. Pat. No. 4,503,047) disclose a composition containing primarily one or more sulfur-containing amino acid(s) and copper(II) ions plus smaller amounts of allyl isothiocyanate and rhodanide ions to produce hair-growth stimulating actions. Pickart (e.g., WO 91/07431, 88/08695 and EP 288,278) found a number of metal complexes of derivatives of Gly-L-His-L-Lys to increase hair follicle size and the rate of hair-growth.
Despite the therapeutic promise of the above- mentioned metal complexes, toxicity and tissue irritation occur with many metal complexes (see, e.g., Johnson et al., Inorq. Chem. Acta. 67: 159-165 (1982); Pickart et al., Biochem. Pharm.. 32: 3868-3871 (1983); and Pickart et al., Lymphokines 8: 425-446 (1983)). For example, while copper- salicylate complexes and numerous copper-salicylate analogs possess anti-inflammatory activities, other salicylate analogs such as the copper(II) complex of salicylaldehyde benzoyl hydrazone are highly toxic to tissues. Similarly, copper(II)- Gly-L-His-L-Lys supports cellular viability and possesses anti-inflammatory and healing actions, yet close synthetic aroylhydrazone analogs of its copper-binding region are extremely toxic to cells and tissues.
Another problem with copper complexes for therapeutic use concerns the binding affinity of copper ion to the complexing molecule. While a defined copper-complex can be synthesized, its therapeutic use places the complex in the physiological milieu of the tissues where a plethora of literally hundreds of compounds compete for binding to the copper ion, which can form electrostatic bonds to as many as six separate molecules. If the copper is removed from the complex and becomes loosely bound, then tissue irritation occurs (see Raju et al., J. Natl. Cancer Inst.. 69: 1183-1188 (1982)) . Further complications arise when such metal complexes are formulated into carrier creams or ointments. Various chemicals are added to the formulations to increase adherence to skin and wound surfaces and to enhance the penetration of the complexes into the target tissue. Yet, since many of these substances also bind to the metals, the expected therapeutic benefits may be nullified or significantly attenuated. Also, detergents such as sodium dodecyl sulfate are used to help blend oil and water phases of the emulsions and stabilize the formulations. However, such detergents are themselves tissue irritants that can delay healing.
Another problem encountered with many of the metal complexes intended for therapeutic use is that they cannot be heat-sterilized; hence, to meet safety requirements, high concentrations of antimicrobial chemicals must be added during manufacture to inhibit the growth of microorganisms and the transmission of viruses. These antimicrobial agents may also inhibit the viability and function of a host's cells such as macrophages and fibroblasts that are involved in the maintenance and repair of skin and other tissue, and thus these agents may retard the healing response.
What is needed in the art are compositions useful in tissue protection, tissue healing, and/or stimulating hair growth, which compositions could be conveniently produced and at low cost. Preferably, the compositions could be sterilized without loss of bioactivity and could be formulated for topical application without the use of detergents or other potentially irritating compounds. The ideal composition would also adhere well to skin and other materials such as wound dressings (for example, adhesive bandages) . To speed the time and expense required for regulatory approvals, the compositions would be prepared from materials that are generally recognized as safe by regulatory agencies and thus could be used with minimal safety concerns and regulatory barriers. Quite surprisingly, the current invention fulfills these and other related needs. Summary of the Invention
The present invention provides compositions and methods for accelerating the healing of topical wounds and skin irritation, for protecting skin from damaging effects of oxidation, and for increasing the size of hair follicles and the rate of hair-growth in warm-blooded animals. The compositions useful in these methods, including pharmaceutical compositions, are prepared from an aloe gel, such as the gel extract of aloe vera, that is complexed with an ionic metal.
Thus, in one aspect the invention provides methods for preparing the pharmaceutical compositions useful in accelerating the healing of topical wounds or increasing hair follicle size and hair growth in a warm-blooded animal. An aloe gel is combined with an aqueous solution of a metal salt, then adjusted to an acceptable acidity range for skin products. Typically, the aloe gel is obtained as a dry powder from commercial sources then reconstituted into a gel with water. The aloe gel is then complexed to an ionic metal such as copper(II) , tin(II) , zinc(II) , etc. This procedure causes a very substantial and significant increase in the wound healing properties of an aloe gel and also produces compositions that markedly stimulate hair growth.
The resulting aqueous mixture is composed of complexes of the aloe gel and the metal ions. The amount of water in the mixture is adjusted to produce a thick but spreadable gel. The resultant gel may be used directly or combined with a pharmaceutically acceptable carrier to form a cream or lotion, in a concentration of from about 10% to about 50% aloe gel-ionic metal complex or more. The preparation may be pasteurized, if desired, without destroying the healing or hair growth stimulating activity of the aloe gel-metal complex.
In other embodiments the invention provides methods for enhancing the recovery of skin of a warm-blooded animal from wounds, such as surgical incisions, burns, inflammation or minor irritation due to oxidative damage, etc. The methods comprise administering to the skin wound or irritation a therapeutically or, in some cases a prophylactically effective amount of a composition which comprises the aloe gel-ionic metal complex. Due to the gel-like composition of the invention, the material is particularly easy to apply to irregular surgical wounds and incisions.
Yet other embodiments relate to compositions and method for increasing hair follicle size and the rate of hair growth in warm-blooded animals, such as humans. The methods comprise administering to the skin in the area in which hair growth is desired an amount of aloe gel-ionic metal complex sufficient to increase hair follicle size and the rate of hair growth in said animal. The composition is administered in a variety of ways, such as topically in a gel or cream, by local injection, etc., and will be typically applied on a regular basis, e.g., daily, until hair growth is observed and for a time thereafter sufficient to maintain the desired amount of hair growth.
Description of the Specific Embodiments
Compositions and methods are provided by the present invention for topical skin treatments to protect damaged skin and thereby allow natural healing processes to proceed, to enhance tissue regenerative processes in the skin of warm blooded animals, and to stimulate hair growth in warm blooded animals. The composition are formed by the complexation of aloe gel and ionic metals such as copper, zinc, tin or the like. Methods are provided for improving the recovery of damaged skin, accelerating the healing of burns or surgical incisions, and stimulating hair growth in warm-blooded animals.
The aloe gel-ionic metal complexes of the present invention are prepared from aloe gel, or extracts from the leaves of plants which are members of the Aloe family (e.g., A. perryi , A. barbadensis, A. capensis and particularly Aloe vera) , or a dried aloe extract in a powdered form which can be reconstituted. Aloe extracts, gels and powders are widely available from commercial sources.
To produce the aloe gel-ionic metal complexes useful in the present invention, the aloe gel, or the aloe powder which is converted to a gel by addition of water, is then complexed via admixture with one or more ionic metals, such as copper, zinc, indium or tin or the salts thereof, such as sulfate, acetate, phosphate, chloride, citrate, succinate, oxalate, cinnamate, tartrate, fumarate, maleate, glutarate, etc. By complexed is meant that the aloe gel and metal ions form electrostatic bonds, although this mechanism is offered by way of explanation only and not by way of limitation. In one method for preparing the aloe gel-metal complex, the aloe gel is mixed with sufficient water (generally at about room temperature, about 22-25°C) to form a thick gel. To obtain this gel, dry aloe powder (1 gram) is mixed with about 2 ml water. The gel is then mixed with a aqueous solution of an ionic metal salt, e.g., copper(II) chloride or tin(II) chloride, at a salt concentration of about 10 to 50% (w/v) , more preferably about 20% (w/v) . The volume of metal salt solution added is generally that amount needed to obtain a final metal concentration in the paste of from about 0.3% up to about 1.2% (weight/weight) or more. As the addition of the metal salt may reduce the pH of the gel, the pH of the gel is then raised to about 6.5. This pH is useful for skin preparations but other pH levels near neutrality or in the slightly acidic range are also efficacious.
The resultant thick gel can be applied directly to the skin or is formulated into skin creams and lotions at concentrations of usually 10 to 50% (w/w) although higher concentration are also effective.
The aloe gel-ionic metal complexes of the invention may be administered for a variety of therapeutic, prophylactic or cosmetic uses to humans or in veterinary applications to other warm-blooded animals. Among veterinary animals particularly well suited for treatment with the present compositions are species of equine, bovine, porcine, ovine, caprine, canine, avian, feline, etc. The compositions and pharmaceutical preparations thereof are intended for local, topical, oral or parenteral (e.g. , subcutaneous injection) administration for prophylactic and/or therapeutic or cosmetic treatment. Preferably, the pharmaceutical compositions are administered locally, e.g., topically, as a paste, cream or salve.
For administration to warm-blooded animals, the aloe gel-ionic metal compositions will typically be sterilized and incorporated in pharmaceutical or veterinary formulations. Compositions which comprise the aloe gel-metal complexes can be sterilized by conventional, well known sterilization techniques, e.g., pasteurization, without substantially adversely affecting the biological activity of the aloe gel- ionic metal complexes. The compositions may contain pharmaceutically acceptable auxiliary substances as required to approximate physiological conditions and as necessary to prepare compositions for convenient administration, such an pH adjusting and buffering agents, and delivery vehicles. Actual methods for preparing pharmaceutically administrable compounds will be known or apparent to those skilled in the art, some of which are described in detail in, for example, Remington's Pharmaceutical Science. Mack Publishing Co., Easton, PA pp. 428-429 (1981) , which is incorporated herein by reference.
Depending on the intended mode of administration and the intended use, the compositions may converted to solid, semi-solid, or liquid dosage forms, such, for example, as powders, granules, crystals, liquids, suspensions, liposomes, pastes, cremes, salves, etc. , and may be in unit-dosage forms suitable for administration of relatively precise dosages. The compositions may include a conventional pharmaceutical carrier or excipient and, in addition, may include other medicinal agents, growth factors, wound sealants, carriers, etc., as further described below.
For semi-solid compositions, as would be appropriate for pastes and creams intended for topical administration, the aloe gel-ionic metal complexes can be provided separately or may be compounded with conventional nontoxic carriers such as, for example, squalane, glycerol sterate, polyethylene glycol, cetyl alcohol, stearic acid, and propylene glycol, among others. Such compositions may contain about 5-100% active ingredient, more preferably about 10-50%. The concentration of the aloe vera gel-ionic metal complexes in these formulations can vary widely, and will be selected primarily by intended use, viscosities, etc., in accordance with the particular mode of administration selected and intended treatment. The composition or formulation to be administered will, in any event, contain a quantity of the aloe gel-metal complexes sufficient to achieve the desired therapeutic or prophylactic effect in the subject being treated.
The tissue healing compositions of the invention are administered to a warm-blooded animal, such as humans, already suffering from a wound, oxidative skin damage, inflammatory skin lesions, as described above, in an amount sufficient to allow the healing process to proceed more quickly than if the host were not treated. In the case of an animal suffering from decreased hair follicle size and impaired hair growth, the compositions of the invention are administered in an amount sufficient to increase hair follicle size and the rate of hair growth. Amounts adequate to accomplish these effects are defined as a "therapeutically effective doses." Amounts effective for these uses will depend on the severity of the wound, sore, etc. , in the case of wound healing, and the extent of decreased follicle size in the case of impaired hair growth, and the general state of health of the patient being treated, but will generally range from about 1 mg to about 25 mg per day of aloe gel-metal complex per day per square centimeter of wound site, with dosages of from about 5 mg to about 10 mg per day per square centimeter of wound site being more commonly used. Maintenance dosages over a prolonged period of time may be adjusted as necessary. For veterinary uses higher levels may be administered as necessary. Determining actual amounts of the aloe gel-metal complexes necessary to treat a particular wound or condition as described above will be through standard empirical methods well known in the art. In prophylactic applications compositions containing the aloe gel-ionic metal complexes are administered to a host susceptible to or otherwise at risk of skin lesions or similar damage, to enhance the host's own wound healing or anti- oxidative capabilities. Such an amount is defined to be a
"prophylactically effective dose." In this use, the precise amounts again depend on the host's condition and general state of health, but generally range from about 0.1 mg to about 10 mg per day per square centimeter of skin, more commonly from about 1 mg to about 3 mg per cm2 of skin per day. Single or multiple administrations of the compositions can be carried out.
The aloe gel-metal complexes of the invention may be administered in relatively large amounts without serious side effects, although indiscriminate use may produce discoloration of the skin. In instances where the compositions are administered to inhibit oxidative or biochemical damage to the skin or to those suffering from only mild irritation or inflammation of the skin, the dose may be adjusted accordingly to lower maintenance levels.
The compositions of the invention, including pharmaceutical compositions may be administered alone or as adjunct therapy or prophylaxis. The aloe vera gel-ionic metal compositions can be used in combination with other compositions, such as described in commonly owned copending US Patent 5,382,431 and patent applications USSN 08/218,392 and 08/219,681, each of which is incorporated herein by reference in its entirety, or with other growth factors known to improve other aspects of healing. In this manner, a synergistic effect may be attained that yields a clinical efficacy greater than that realized with any single factor. Further, while the compositions described herein stimulate a spectrum of healing processes, clinical wounds may differ considerably in their properties and healing patterns, leading one to utilize a combination of a composition described herein and another factor. For example, nerve regeneration is defective in many burns and thus one can add a specific nerve growth factor to supplement the composition to enhance nerve regrowth into the burn area. Examples of factors with other reported healing properties include epidermal growth factor, fibroblast growth factor, nerve growth factor, transforming growth factors, angiogenic growth factors, heparin, fibronectin, fibrin, platelet-derived growth factor, enzymatic superoxide dismutase, extracts of blood or factors from the blood, and other similar factors.
The following examples are offered by way of illustration, not by way of limitation.
EXAMPLE I Preparation of Active Aloe Vera Gel-Ionic Metal Complexes
This Example describes methods used in the preparation of the aloe vera gel-ionic metal complexes having biological activities described further below. Aloe vera gel extract in a dry powdered form was purchased from Agro-Mar, Lakes, Nevada. Cupric chloride was from Sigma Chemical
Company, St. Louis, MO while tin (II) chloride, 99% pure was purchased from Aldrich Chemical Company, Milwaukee, WI.
In one method for preparing the aloe vera gel-ionic metal gel complex, the aloe vera gel was mixed with sufficient water (at room temperature, about 23 °C) to form a thick gel. To obtain this gel, dry aloe vera powder (1 gram) was mixed with 2 is water. The gel was then mixed with a aqueous solution of a metal salt (copper(II) chloride or tin(II) chloride at a salt concentration of 20% (w/v) . The volume of metal salt solution added is that amount needed to obtain a final metal concentration in the paste of 0.3 to 1.2% (weight/weight) . The addition of the metal salt reduced the pH of the gel to about 2.9. The pH of the gel was then raised to 6.5 by careful addition of 1 N sodium hydroxide. The aloe vera gel-copper complexes were used as skin protective agents that served as a skin barrier over damaged or irritated skin. The gel adhered to the skin and formed a protective barrier, while the complexed copper serves to impart an antioxidant activity to the mixture. As shown below, damaged or irritated skin healed strikingly faster after treatment with such a composition.
As also described further below, the aloe vera gel- copper and aloe vera gel-tin were used to promote hair growth and the enlargement of hair follicles. In hair growth models in mice, application of these complexes to the skin produced a marked stimulation of hair growth after 8 to 12 days.
Other types of aloe vera gel-metal complexes, e.g., aloe from other plants, other salts of the metals, such as sulfate, acetate, phosphate, and so forth would be expected to work similarly.
EXAMPLE II
Healing of Surgical Wounds with Aloe Vera Gel-Copper Complexes
This Examples describes the use of a gel prepared with the aloe vera gel-copper complexes to hasten the healing of surgical incision wounds in animals.
Surgical incisions (1.25 cm) were made on the backs of anesthetized, 35 gram, Swiss-Webster mice. Immediately after surgery and 24 hours later, the wounds were covered with a thin film of the paste containing the active aloe vera gel-copper complex in Example I above.
Control wounds were untreated or were treated with aloe vera not containing the copper. As seen in Table 1, wounds treated with the active aloe vera gel-copper complex healed faster than control wounds. In contrast, aloe vera gel without copper ion had no significant healing action in this model.
Since rapidly healing wounds tends to contract and become more rounded, the healing activity can be related to the length of the wound after 9 days. Each group consisted of eight mice. Table 1: Effect of aloe vera gel-copper complex on incision length.
Test group Length of wound after 9 days (cm.)
Control 0.87 + 0.15
Aloe vera gel- 0.90 ± 0.16 no copper
Aloe vera gel-
1.0% copper complex 0.46 ± 0.03 Aloe vera gel-
0.3% copper complex 0.54 + 0.10
EXAMPLE III Healing of Burn Wounds with Aloe Vera Gel-Copper Complex
This Example demonstrates the increased healing of burn wounds in animals using the aloe vera gel-copper compositions applied topically.
Second-degree burns were induced on the shaved backs on anesthetized mice by placing a circular (1.25 cm diameter, wound area = 1.22 cm2) brass rod (temperature 100°C) in contact the skin for 7 seconds. Immediately after burning, and 24 and 48 hours later, the wounds were covered with a thin film of the paste containing the active aloe vera gel-copper complex of Example I above. Control wounds were untreated or were treated with an aloe vera gel without copper. Wounds were traced on anesthetized mice, digitized from an computerized scanning bed, and area calculated from the computerized pixel number. Burns treated with the active aloe vera gel copper complexes showed less post-burn inflammation and healed markedly faster than untreated control wounds or wounds treated with an aloe vera gel without copper. Table 2: Effect of aloe vera gel-copper complex on burn wounds.
Test group Area of wound after 15 days (cm2)
Control 0.85 ± 0.07
Aloe vera gel 0.79 ± 0.14 without copper
Aloe vera gel- 0.52 ± 0.08
0.3% copper complex Aloe vera gel- 0.46 ± 0.04
1.0% copper complex
EXAMPLE IV Reduction in Post-Burn Inflammation of Skin
This Example demonstrates the ability of aloe vera gel-copper complex to reduce inflammation associated with mild skin burns.
Very mild thermal burns were induced on the shaved backs of anesthetized mice (8 mice in each group) by a placing a circular (1.25 cm diameter, irritated area = 1.22 cm2) brass rod (60°C) in contact the skin for 5 seconds. This produced a mild skin irritation characterized by redness and swelling, but rarely a loss of skin tissue. Immediately after inducing the thermal injury, the irritated area was covered with a thin film of the gel containing one of the following: aloe vera gel without copper, aloe vera gel with 0.3% copper ion, aloe vera gel with 1.0% copper ion. Control wounds were untreated. Wounds were observed at daily intervals. At day 3, the untreated thermal injuries were still reddish and swollen while the skin with any of the three aloe vera gel-copper complexes had minimal reddishness and swelling. Aloe vera gel without copper gave a slight improvement in skin condition but much less than the copper-containing complexes. EXAMPLE V Pasteurization of Active Aloe Vera Gel-Copper Composition
Pasteurization consists of heating a solution to
160° for 30 minutes which kills all but the hardiest microorganisms. For this test, various aloe vera gels were complexed with copper chloride by the methods described above in Example I. The resultant gels were then heated to 160°F for 30 min. After cooling to room temperature, the gels were applied to surgical incision wounds in mice in the manner described in Example II. Healing activity was similar to that observed with unpasteurized active composition, as shown in Table 3. Each group contained six mice.
Table 3: Effect of pasteurization on active complex.
Test group Length of wound after 9 days (cm)
Control 0.94 ± 0.10
Aloe vera gel 0.91 + 0. 14 no copper
Aloe vera gel-
1.0% copper complex 0.49 ± 0.11
Aloe vera gel- 0.3% copper complex 0.53 ± 0.11
EXAMPLE VI
Adherence of Aloe vera gel-Copper paste to Skin
This Example describes the use of a aloe vera gel- copper active complex to improve the adherence of a wound dressings to the surface of the skin. The aloe vera gel- copper complexes can thus be used to more effectively cover and seal wounds with dressings. Also, many tapes used to hold medical sensors to the skin or catheters in veins cause skin irritation. The incorporation of an aloe vera gel-copper complex into the adhesive used on such tapes could reduce such skin irritation and injury.
For testing, the wound coverage area of a Band Aid™ brand adhesive bandage was cut away from the adhesive area. The wound coverage area of the tape, which has no skin adhesive qualities, was covered with the aloe vera gel with 0.3% copper ion. The paste-covered tape was applied to the upper arm of humans and left in place during normal work functions in an office. The tape adhered well to the skin during the subsequent 8 hour test. This demonstrates that such wound-healing pastes possessed significant adhesive properties on human skin.
EXAMPLE VII
Stimulation of Hair Growth
This Example describes the use of compositions containing aloe vera gel-copper complexes to stimulate the growth of hair follicles in warm blooded animals. The model used in this test was a mouse model that has been found to successfully predict the therapeutic response in humans (see, e.g., U.S. Pat. No. 5,118,665, which is incorporated herein by reference) . Hair growth in mammals proceeds through actively growing stages (anagen) followed by dormant stages (telogen) . The test method generally involved applying the hair growth stimulant to the skin of mice in telogen phase. Female, Swiss-Webster mice begin a telogen phase at about 45 days of age that lasts until about 90 days of age. After application of the active substance, enhanced hair growth is noted within 10 to 14 days. For this test, mice 50 days of age were used.
Aloe vera gel compositions containing copper(II) and tin(II) were tested. For testing, the aloe vera gel-metal pastes were mixed with saline (25% aloe vera gel composition and 75% physiological saline by weight) . Mice were shaved, then 0.05 ml of the mixture was infiltrated immediately below the skin by injection. Control mice were injected with an equal volume of saline. Each group contained 10 mice. After 12 days, the groups were compared. The percentage of mice with hair growth at the injection site and the relative strength of the hair growth response (on a scale of 1 to 5 where 1 is barely noticeable growth and 5 is very strong hair growth) were determined. The results, shown in Table 4, indicate that the compositions were active hair growth stimulants, with aloe vera gel-tin(II) complexes being the most effective agent.
Table 4: Stimulation of hair growth by Aloe vera gel-Metal
Complexes.
Percent with hair growth Average intensity at injection site of hair growth
Control mice 0 0
Aloe vera gel-no 0 0 copper(II)
Aloe vera gel-1% 100 2.0 copper(II) Aloe vera gel-1% 100 2.5 tin(II)
It is evident from the above results that the subject invention provides compositions of aloe vera gel-ionic metal complexes for topical skin, wound and surgical treatments to protect damaged skin and facilitate natural healing processes, to enhance tissue regenerative processes in the epidermis, and to stimulate hair growth in warm blooded animals. The invention also provides economical methods for preparing and formulating the compositions for topical administration.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A method for accelerating the healing of topical wounds in a warm-blooded animal which comprises: administering to the wound a therapeutically effective amount of a composition which comprises an aloe gel complexed with an ionic metal.
2. The method of claim 1, wherein the ionic metal is copper(II) , and therapeutically acceptable salts thereof.
3. A method for enhancing the recovery of skin of a warm-blooded animal from irritation, comprising: administering to the skin irritation a therapeutically effective amount of a composition which comprises an aloe gel complexed with an ionic metal.
4. The method of claim 3 where the ionic metal is copper(II) .
5. A method for protecting the skin from oxidative damage and aiding the recovery of skin wounds in a warm blooded animal, comprising: administering to the skin or wound site a prophylactically or therapeutically effective amount of a composition which comprises a aloe gel complexed with an ionic metal.
6. The method of claim 5, wherein the ionic metal is copper(II) , and therapeutically acceptable salts thereof.
7. A method for increasing hair follicle size and the rate of hair growth in a warm-blooded animal, comprising: administering to the skin of said animal a composition which comprises a aloe gel complexed with an ionic metal in an amount sufficient to increase hair follicle size and the rate of hair growth in said animal.
8. The method of claim 7, wherein the composition is administered by injection into the skin.
9. The method of claim 7, wherein the ionic metal is copper(II) or tin(II) , and therapeutically acceptable salts thereof.
10. The method of claim 9, wherein the ionic metal is tin(II) .
11. A composition useful for accelerating the healing of topical wounds of a warm-blooded animal which comprises a therapeutically effective amount of a aloe gel complexed with an ionic metal.
12. The composition of claim 11, wherein the ionic metal is copper(II) or tin(II) , and therapeutically acceptable salts thereof.
13. The composition of claim 11, wherein the ionic metal is copper(II) .
14. The composition of claim 11, further comprising a pharmaceutically acceptable carrier.
15. The composition of claim 11, wherein the aloe gel-metal complex is present at a concentration of 10% to 50%.
16. A pharmaceutical composition for increasing hair follicle size and rate of hair growth in a warm-blooded animal, which comprises a hair growth stimulating amount of a aloe gel-ionic metal complex and a pharmaceutically acceptable carrier.
17. The pharmaceutical composition of claim 16, wherein the aloe gel-ionic metal complex is present in the composition at a concentration of 10% to 50%.
18. The pharmaceutical composition of claim 16, wherein the ionic metal is copper(II) or tin(II), and therapeutically acceptable salts thereof.
19. The pharmaceutical composition of claim 16, which is formulated for topical administration.
20. The pharmaceutical composition of claim 16, which has been sterilized by heating or pasteurized.
PCT/US1995/003777 1994-03-28 1995-03-27 Metal complexes of aloe extracts for skin and hair WO1995026198A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21961/95A AU2196195A (en) 1994-03-28 1995-03-27 Metal complexes of aloe extracts for skin and hair

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21904794A 1994-03-28 1994-03-28
US08/219,047 1994-03-28

Publications (1)

Publication Number Publication Date
WO1995026198A1 true WO1995026198A1 (en) 1995-10-05

Family

ID=22817623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/003777 WO1995026198A1 (en) 1994-03-28 1995-03-27 Metal complexes of aloe extracts for skin and hair

Country Status (2)

Country Link
AU (1) AU2196195A (en)
WO (1) WO1995026198A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801554A1 (en) * 1994-12-21 1997-10-22 Cosmederm Technologies Formulations and methods for reducing skin irritation
WO2011069184A1 (en) * 2009-12-08 2011-06-16 Dynamiclear Pty Ltd Composition for treating skin lesions
US8147855B2 (en) 1994-12-21 2012-04-03 Cosmederm Bioscience, Inc. Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium
US8828941B2 (en) 2007-02-23 2014-09-09 Divya Diwan Composition and method for the treatment or prevention of spinal disorders
WO2015114181A1 (en) 2014-01-30 2015-08-06 Tello De Juan Maria Del Mar Cold natural aloe vera gel without stabilisers

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465629A (en) * 1983-03-17 1984-08-14 Maughan Rex G Method to increase color fastness of stabilized aloe vera
US4708873A (en) * 1986-01-29 1987-11-24 Schulte Thomas L Method of chemically debriding uncerated necrotic tissue
US4877770A (en) * 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5294434A (en) * 1991-04-22 1994-03-15 King Ronald M Aloe vera gel toothpaste
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465629A (en) * 1983-03-17 1984-08-14 Maughan Rex G Method to increase color fastness of stabilized aloe vera
US4877770A (en) * 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US4708873A (en) * 1986-01-29 1987-11-24 Schulte Thomas L Method of chemically debriding uncerated necrotic tissue
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5294434A (en) * 1991-04-22 1994-03-15 King Ronald M Aloe vera gel toothpaste
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801554A1 (en) * 1994-12-21 1997-10-22 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0801554A4 (en) * 1994-12-21 2000-03-29 Cosmederm Technologies Formulations and methods for reducing skin irritation
US6455076B1 (en) 1994-12-21 2002-09-24 Gary S. Hahn Formulations and methods for reducing skin irritation
US8147855B2 (en) 1994-12-21 2012-04-03 Cosmederm Bioscience, Inc. Methods for inhibiting sensory responses in the skin such as pain and itch using topical product formulations containing strontium
US8449923B2 (en) 1994-12-21 2013-05-28 Cosmederm Bioscience, Inc. Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin
US8828941B2 (en) 2007-02-23 2014-09-09 Divya Diwan Composition and method for the treatment or prevention of spinal disorders
US9480819B2 (en) 2007-02-23 2016-11-01 Divya Diwan Composition and method for the treatment or prevention of spinal disorders
US10322166B2 (en) 2007-02-23 2019-06-18 Kunovus Pty Ltd Composition and method for the treatment or prevention of spinal disorders
WO2011069184A1 (en) * 2009-12-08 2011-06-16 Dynamiclear Pty Ltd Composition for treating skin lesions
WO2015114181A1 (en) 2014-01-30 2015-08-06 Tello De Juan Maria Del Mar Cold natural aloe vera gel without stabilisers

Also Published As

Publication number Publication date
AU2196195A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
US5382431A (en) Tissue protective and regenerative compositions
US5888522A (en) Tissue protective and regenerative compositions
US5858993A (en) Starch-metal complexes for skin and hair
MXPA96004387A (en) Complexes metal starch for skin and head
US5529987A (en) Hyaluronic acid-urea pharmaceutical compositions and uses
US8183204B2 (en) Methods and compositions for increasing skin remodeling
CA1286988C (en) Use of ghl-cu as a wound-healing and anti-inflammatory agent
JP6495183B2 (en) Compositions and methods for treating surface wounds
US5550112A (en) Hyaluronic acid-urea pharmaceutical compositions and uses
US5420114A (en) Methods for the treatment of skin disorders
WO1995026198A1 (en) Metal complexes of aloe extracts for skin and hair
AU709422B2 (en) Method for topical treatment of scar tissue and related tissue reaction to trauma
US5616619A (en) Topical composition for burn relief and method of use
WO1995026194A1 (en) Allantoin-metal complexes for skin and hair
CA2126704C (en) Dermatological compositions and methods for the treatment of skin therewith
CA2256093C (en) Topical pharmaceutical compositions for healing wounds
AU687840B2 (en) Topical composition for burn relief and method of use
MXPA00005595A (en) Topical zinc compositions and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA